Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer
Yanpeng Xiong,* Liang Zhou,* Zijie Su, Jiaxing Song, Qi Sun, Shan-Shan Liu, Yuqing Xia, Zhongyuan Wang, Desheng LuGuangdong Key Laboratory for Genome Stability and Disease Prevention, Shenzhen University International Cancer Center, Department of Pharmacology, Shenzhen University Health Science Cent...
Main Authors: | Xiong Y, Zhou L, Su Z, Song J, Sun Q, Liu SS, Xia Y, Wang Z, Lu D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/longdaysin-inhibits-wntbeta-catenin-signaling-and-exhibits-antitumor-a-peer-reviewed-article-OTT |
Similar Items
-
CK19 Promotes Ovarian Cancer Development by Impacting on Wnt/β-Catenin Pathway
by: Lu Q, et al.
Published: (2020-03-01) -
CK1ε and p120‐catenin control Ror2 function in noncanonical Wnt signaling
by: Josué Curto, et al.
Published: (2018-05-01) -
Radix Tetrastigma hemsleyani flavone exhibits antitumor activity in colorectal cancer via Wnt/β-catenin signaling pathway
by: Wu X, et al.
Published: (2018-10-01) -
Wnt/β-Catenin Pathway-Mediated PPARδ Expression during Embryonic Development Differentiation and Disease
by: Tabinda Sidrat, et al.
Published: (2021-02-01) -
Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
by: Xi-Feng Jin, et al.
Published: (2020-02-01)